emat

Buy Complete Report

Prix: €120 HT

Logo CreditCards Visa Logo CreditCards Mastercard

This report is accessible on EMAT, the reference database for private company acquisition multiples

 

 

► Subscribe to EMAT database

 

Sectors covered by our analysts

 

► Studies & indices published by Epsilon Research: Register to receive (free) publications updates

 

► Alert on reports published: Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.

 

Transaction Multiples for the Valuation of Private Companies

Bringwell International / Cardinova AB, Validus NnP AS and Nordic Nature Pharma AB

No EMAT : 20913
Announced Date : 24/04/2007
Type : Acquisition of Majority Stake
Deal Value : Yes
Acquirer : Bringwell International

Target : Cardinova AB, Validus NnP AS and Nordic Nature Pharma AB
Country : Sweden
Sector of activity :
  • Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
  • Food Producers > Food & Beverage Industry > Food Complements
  • Food & Drink R&W > Retail and Wholesale ('R&W') > Food R&W
Business Description :
Cardinova AB , a pharmaceutical company, develops and manufactures natural medicines . It produces pharmaceuticals, natural pharmaceuticals, food supplements and ingredients for the food industry. >...

Transaction multiples available
EV/
Sales
EV/
Gross Profit
EV/
EBITDA
EV/
EBIT
Eq/
PBT
P/E Price
to Book
Specific
multiple(s)
Historic
Current
Rating : *
Multiple available
n.s.   Multiple calculated, but not significant

Source: Epsilon Research / EMAT

Comparable Transactions

  • Number of EMAT Reports / sub-sector « Pharmaceuticals » = 131
  • Number of EMAT Reports / sub-sector « Food Complements » = 123
  • Number of EMAT Reports / sub-sector « Food R&W » = 69
Example of comparable transactions on EMAT (same sub-sector):
Date Acquirer Target Country Multiples See details
14/12/2006 Nestle Novartis Medical Nutrition Switzerland ** 20912
17/06/2008 NeutraHealth Perrigo UK (Brunel Healthcare Manufacturing Ltd) United Kingdom *** 20909

Source: Epsilon Research / EMAT

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

 

► Example of EMAT Report